Wird geladen...
Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: Implications of imatinib mesylate
AIM: To examine the impact of imatinib mesylate (Glivec) on patient survival and response and its safety, and the correlation of the response rate with the kit gene mutation status. METHODS: Thirty-three of 74 (44.6%) small bowel gastrointestinal stromal tumor (GIST) patients who developed recurrenc...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Co., Limited
2006
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4087472/ https://ncbi.nlm.nih.gov/pubmed/16773696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i23.3760 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|